今开:0.0 | 昨收:30.0 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:2.00054076E9 |
$NxStage Medical, Inc.(NXTM)$ 内部交易: 2017-09-20,SVP and General Counsel,Swan Winifred L ,卖出,3500普通股, $27.27
$NxStage Medical, Inc.(NXTM)$ 内部交易: 2017-09-20,SVP and General Counsel,Swan Winifred L ,期权,3000普通股, $11.03
$NxStage Medical, Inc.(NXTM)$ 内部交易: 2017-09-12,Director,Mixer Jean K ,期权,18196普通股, $13.60
$NxStage Medical, Inc.(NXTM)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-09-11 AccNo: 0000315066-17-002770 Size: 9 KB 网页链接
$NxStage Medical, Inc.(NXTM)$ PREM14A - Preliminary proxy statements relating to merger or acquisition Filed: 2017-09-06 AccNo: 0001193125-17-277904 Size: 1 MB 网页链接
$NxStage Medical, Inc.(NXTM)$ 内部交易: 2017-08-21,SVP and Chief Financial Office,TOWSE MATTHEW W ,卖出,4300普通股, $29.22
$NxStage Medical, Inc.(NXTM)$ 内部交易: 2017-08-21,SVP and Chief Financial Office,TOWSE MATTHEW W ,期权,4300普通股, $14.05
$NxStage Medical, Inc.(NXTM)$ 内部交易: 2017-08-15,SVP and General Counsel,Swan Winifred L ,卖出,3500普通股, $29.21
$NxStage Medical, Inc.(NXTM)$ 内部交易: 2017-08-15,SVP and General Counsel,Swan Winifred L ,期权,3000普通股, $11.03
$NxStage Medical, Inc.(NXTM)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-08-11 AccNo: 0001144204-17-042487 Size: 60 KB 网页链接